זיאגן טבליות
glaxo smith kline (israel) ltd - abacavir as sulfate 300 mg - tablets - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected adults and children.
זיאגן טבליות
glaxo smith kline (israel) ltd - abacavir as sulfate - טבליות מצופות פילם - abacavir as sulfate 300 mg - abacavir - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected adults and children.
זיאגן תמיסה לשתיה
glaxo smith kline (israel) ltd - abacavir as sulfate - תמיסה (פומי) - abacavir as sulfate 20 mg/ml - abacavir - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected adults and children.
רלנזה
glaxo smith kline (israel) ltd - zanamivir micronized - אבקה לשאיפה - zanamivir micronized 5 mg - zanamivir - zanamivir - zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza a and b virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.
רלנזה
glaxo smith kline (israel) ltd - zanamivir micronized - אבקה לשאיפה - zanamivir micronized 5 mg - zanamivir - zanamivir - zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza a and b virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.
היבריקס
glaxo smith kline (israel) ltd - haemophilus influenzae type b polysaccharide 10 mcg / 0.5 ml - powder for solution for injection - hemophilus influenzae b, purified antigen conjugated - active immunisation for all infants from the age of two months against disease caused by hib
סינפלוריקס
glaxo smith kline (israel) ltd - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19 f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 9v - תרחיף להזרקה - pneumococcal polysaccharide serotype 19 f 3 mcg / 0.5 ml; pneumococcal polysaccharide serotype 1 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 4 3 mcg / 0.5 ml; pneumococcal polysaccharide serotype 5 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6b 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 7f 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 9v 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 14 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 18c 3 mcg / 0.5 ml; pneumococcal polysaccharide serotype 23f 1 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen conjugated - pneumococcus, purified polysaccharides antigen conjugated - active immunisation of infants and children from 6 weeks up to 5 years of age against invasive disease and acute otitis media caused by streptococcus pneumoniae serotypes 1, 4, 5, 6b, 7f, 9v, 14, 18c, 19f, and 23f.
בוסטריקס
glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); pertactin (prn or 69 kda omp); pertussis toxoid (pt); tetanus toxoid - תרחיף להזרקה - diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid (pt) 8 mcg / 0.5 ml; pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml - tetanus toxoid, combinations with diphtheria toxoid - tetanus toxoid, combinations with diphtheria toxoid - for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of ten years onwards.
אינפנריקס - hib
glaxo smith kline (israel) ltd - diphtheria toxoid 30 iu / 0.5 ml; filamentous haemogglutinin (fha) 25 mcg / 0.5 ml - powder and suspension for suspension for injection - tetanus toxoid, combinations with diphtheria toxoid - active immunisation of all infants from the age of 2 months to 7 years of age against diptheria, tetanus, pertussis (dtp) and hib.
טיפריקס
glaxo smith kline (israel) ltd - salmonela typhi vi polysaccharide 25 mcg / 0.5 ml - solution for injection - typhoid, purified polysaccharide antigen - active immunisation against typhoid fever, for adults and children older than two years of age.